CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with early stage breast cancer | Dr Hyman Muss at Annual Meeting 2015 - 101271

Spotlight
Video

CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with early stage breast cancer | Dr Hyman Muss at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides an update on the CALGB/CTSU/Alliance 49907 trial, which compared capecitabine with standard chemotherapy in patients with breast cancer who were at least 65 years old.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 08/20/15
Added : 3 years ago
Category : Breast Cancer